TCL Archive DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program April 8, 1983
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006